Skip to main content
Clinical Trials/NCT04666792
NCT04666792
Completed
Phase 4

PrEParing Family Planning Clinics to Streamline Integration of HIV Prevention Services for Young Women in Kenya

University of Washington1 site in 1 country25,457 target enrollmentMarch 1, 2021
InterventionsPrEP
DrugsPrEP

Overview

Phase
Phase 4
Intervention
PrEP
Conditions
HIV Infections
Sponsor
University of Washington
Enrollment
25457
Locations
1
Primary Endpoint
Proportion of women accessing family planning services who are screened for HIV risk
Status
Completed
Last Updated
8 months ago

Overview

Brief Summary

This a prospective, open-label implementation project to catalyze integration of HIV prevention and PrEP care services for adolescent girls and young women in family planning clinics in Kenya.

Detailed Description

Investigators will conduct a stepped-wedge cluster-randomized programmatic project to integrate PrEP provision within a combination HIV prevention package in 12 family planning clinics in Kisumu, Kenya- a region with an HIV prevalence of up to 28% among young women. The project will optimize and sustain PrEP delivery with existing family planning staff, supported through training and ongoing technical assistance. The investigators will rigorously evaluate program reach, effectiveness, adoption, implementation, maintenance, and impact using validated implementation science frameworks and how clinics build new efficient delivery systems.

Registry
clinicaltrials.gov
Start Date
March 1, 2021
End Date
December 31, 2024
Last Updated
8 months ago
Study Type
Interventional
Study Design
Single Group
Sex
Female

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Kenneth K Mugwanya

Assistant Professor, Global Health, School of Medicine and School of Public Health,

University of Washington

Eligibility Criteria

Inclusion Criteria

  • Female of reproductive age
  • Sexually active
  • Able and willing to provide informed consent
  • HIV negative, according to national HIV testing algorithm
  • Has at least one risk factor for HIV as defined by the Kenya National AIDS and STI Control Program

Exclusion Criteria

  • \- Otherwise not eligible based on the above inclusion criteria

Arms & Interventions

PrEP for HIV-1 uninfected for women accessing family planning

Women accessing family planning will be assessed for HIV risk and PrEP eligibility. If eligible and willing to initiate PrEP, they will be provided PrEP in accordance with national guidelines as part of their standard of care at the family planning clinic.

Intervention: PrEP

Outcomes

Primary Outcomes

Proportion of women accessing family planning services who are screened for HIV risk

Time Frame: up to 24 months

Measure HIV risk screening completion among women receiving family planning services

Proportion of women accessing family planning services who uptake PrEP for HIV prevention

Time Frame: up to 24 months

Measure PrEP initiation among women receiving family planning services

Secondary Outcomes

  • Develop data tools to expand and support delivery of family planning and HIV prevention services(up to 24 months)
  • Proportion of family planning clinics that implement PrEP provision(up to 36 months)
  • Proportion of targeted providers who are trained and provide PrEP(up to 24 months)
  • Facilitators and barriers to PrEP implementation(up to 24 months)
  • Proportion of women who remain HIV-negative(up to 24 months)
  • Programmatic costs of providing PrEP in family planning clinics(up to 24 months)
  • Proportion of core PrEP delivery components delivered per protocol(up to 24 months)
  • PrEP adherence quantified by tenofovir drug levels in blood(up to 24 months)

Study Sites (1)

Loading locations...

Similar Trials